Edition:
United States

People: Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,546JPY
19 Jan 2017
Change (% chg)

¥2 (+0.10%)
Prev Close
¥1,544
Open
¥1,548
Day's High
¥1,561
Day's Low
¥1,543
Volume
7,324,000
Avg. Vol
7,555,050
52-wk High
¥1,779
52-wk Low
¥1,358

Hatanaka, Yoshihiko 

Mr. Yoshihiko Hatanaka was named President, Chief Executive Officer, Chairman of the Board of Directors and Representative Director in Astellas Pharma Inc. effective June 20, 2016. He previously served as Executive Officer and Senior Executive Officer in the Company, as well as President and Chief Executive Officer in two US-based subsidiaries. He used to work for Fujisawa Pharmaceutical Co., Ltd. He obtained his bachelor's degree in Economics from Hitotsubashi University in May 1980.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --